Lacarnit Tablet is utilized for treating carnitine deficiency. Its specific applications include:
Primary Systemic Carnitine Deficiency (SPCD): Lacarnit Tablet addresses SPCD, a genetic disorder that hinders carnitine transport, by replenishing carnitine levels in the body.
Secondary Carnitine Deficiency (SCD): Lacarnit Tablet is effective in managing both acute and chronic SCD resulting from inherited metabolic disorders (like propionic acidemia, methylmalonic aciduria, and medium-chain acyl-CoA dehydrogenase deficiency) by facilitating the removal of harmful organic acids.
Dialysis-Related Deficiency: Lacarnit Tablet aids in preventing and treating carnitine deficiency in patients with end-stage renal disease who are undergoing dialysis.
Cardiac Support: Lacarnit Tablet contributes to alleviating symptoms and enhancing exercise capacity in individuals experiencing heart-related issues.
Hypothyroidism Symptoms: Lacarnit Tablet assists in reducing symptoms such as palpitations (rapid or forceful heartbeat), anxiety, and fatigue linked to elevated thyroid hormone levels.
Male Fertility: Lacarnit Tablet is employed either alone or alongside acetyl-L-carnitine to boost sperm count and motility in men facing fertility challenges.
Weight Management: Lacarnit Tablet may assist in lowering body weight, body mass index (BMI), and fat mass, especially in adults who are overweight or obese.
Cognitive Support: Lacarnit Tablet may provide advantages in enhancing cognitive function or slowing cognitive decline in individuals with neurodegenerative conditions (such as Parkinson's disease).
